ɾ³ý»ò¸üÐÂÐÅÏ¢£¬ÇëÓʼþÖÁfreekaoyan#163.com(#»»³É@)

È«ÇòÉúÎï²úÒµ·¢Õ¹ÏÖ×´¼°Õþ²ßÆôʾ

±¾Õ¾Ð¡±à Free¿¼Ñп¼ÊÔ/2021-12-26

°×¾©Óð1, ÁÖÏþ·æ1, ÒüÕþÇå2
1. ¹ú¼Ò·¢Õ¹ºÍ¸Ä¸ïίԱ»á´´ÐÂÇý¶¯·¢Õ¹ÖÐÐÄ£¬±±¾© 100037;
2. ÖйúÅ©Òµ´óѧ ÐÅÏ¢ÓëµçÆø¹¤³ÌѧԺ£¬±±¾© 100083
ÊÕ¸åÈÕÆÚ£º2020-05-09£»½ÓÊÕÈÕÆÚ£º2020-07-29

ÕªÒª£ºÉúÎï¾­¼Ãʱ´úÕýÔÚÒý·¢ÈËÀàÐÂÒ»²¨¼¼ÊõºÍ²úÒµ¸ïÃü£¬²¢ÒѳÉΪÁËÈ«ÇòÖ÷Òª·¢´ï¹ú¼ÒºÍÐÂÐ˾­¼ÃÌåÇÀÕ¼µÄÖƸߵ㡣ÎÄÖдÓÉúÎïÒ½Ò©²úÒµ¡¢×ª»ùÒò×÷ÎïÖÖÖ²²úÒµ¡¢ÉúÎïÄÜÔ´²úÒµÒÔ¼°ÉúÎï»ù»¯Ñ§Æ·²úÒµ4¸ö½Ç¶È·ÖÎöÁËÈ«ÇòÉúÎï²úÒµ·¢Õ¹µÄʱ¿ÕÌØÕ÷£¬¸ÅÀ¨×ܽáÁËÈ«ÇòÉúÎï²úÒµ·¢Õ¹µÄÖ÷ÒªÌص㣬²¢½øÒ»²½Õë¶ÔÎÒ¹úÉúÎï²úÒµ·¢Õ¹ÖдæÔÚµÄÆ¿¾±ÎÊÌâÌá³öÕþ²ß½¨Ò飬¶ÔÎÒ¹úÉúÎï¾­¼ÃµÄδÀ´·¢Õ¹¾ßÓÐÖ¸µ¼ÒâÒå¡£
¹Ø¼ü´Ê£ºÉúÎïҽҩת»ùÒòÅ©×÷ÎïÉúÎïÄÜÔ´ÉúÎï»ù»¯Ñ§Æ··¢Õ¹ÏÖ×´Õþ²ß½¨Òé
Status quo of global bioindustry and its policy implications
Jingyu Bai1, Xiaofeng Lin1, Zhengqing Yin2
1. Innovation Driven Development Center, National Development and Reform Commission, Beijing 100037, China;
2. College of Information and Electrical Engineering, China Agricultural University, Beijing 100083, China
Received: May 9, 2020; Accepted: July 29, 2020
Corresponding author: Zhengqing Yin. Tel: +86-10-62737653; E-mail: yzq_cau@163.com.

Abstract: The advent of the bioeconomy era is triggers a new wave of technology and industrial revolution. Bioeconomy has become the commanding heights that major developed countries and emerging economies try to seize. This paper analyzes the spatiotemporal characteristics of global bioindustry development from four perspectives: biomedical industry, genetically modified crop planting industry, bioenergy industry, and bio-based chemical industry. Then it summarizes the main characteristics of the development of the global bioindustry, and further put forward policy recommendations for the bottleneck problems in the development of China's bioindustry, which can guide the future development of China's bioeconomy.
Keywords: biomedicinegenetically modified cropsbioenergybio-based chemicalsdevelopment statuspolicy recommendation
¡¶Ê±´úÖÜ¿¯¡·ÔøÖ¸³ö£¬µ½2020ÄêÉúÎï¾­¼Ãʱ´ú½«³ÉΪÈËÀà¼ÌÐÅÏ¢¾­¼Ãʱ´ú½áÊøºóÂõÈëµÄÏÂÒ»¸ïÃüÐÔ²úÒµ¾­¼Ãʱ´ú[1]¡£ÉúÎï¾­¼Ã½«ÊDzúÉúÖÇÄÜÔö³¤ºÍ°üÈÝÐÔÔö³¤£¬¼õÉÙ¶Ô»¯Ê¯È¼ÁϵÄÒÀÀµ£¬¼õÉÙÄÜÔ´ºÍ×ÊÔ´ÏûºÄ£¬´´ÔìÂÌÉ«¾ÍÒµ»ú»áºÍ´Ù½ø¿É³ÖÐø·¢Õ¹µÄÖ÷Òª¶¯Á¦¡£ÉúÎï²úÒµÊÇÉúÎï¾­¼ÃµÄÖØÒª×é³É²¿·Ö£¬µ±Ç°ÊÀ½ç¸÷Ö÷Òª·¢´ï¹ú¼ÒºÍÐÂÐ˾­¼ÃÌå·×·×¾ÍÉúÎï²úÒµ·¢Õ¹×÷³öÁËÕ½ÂÔ²¿Êð¡£
ÃÀ¹ú°×¹¬ÓÚ2012Äê·¢²¼µÄÃÀ¹úÖ§³ÖÉúÎï¾­¼ÃµÄ¹ú¼ÒÉúÎï¾­¼ÃÀ¶Í¼[2]°üÀ¨Ö§³Ö»ùÒò¹¤³Ì¡¢DNA²âÐòºÍÉúÎï·Ö×ÓµÄ×Ô¶¯»¯¸ßͨÁ¿²Ù×÷£»Í¬Ä꣬ŷÃËίԱ»áͨ¹ýÁË¡¶´´ÐÂÒÔʵÏֿɳÖÐøÔö³¤£ºÅ·ÖÞµÄÉúÎï¾­¼Ã¡·Õ½ÂÔ[3]£¬Ìá³ö·¢Õ¹ÉúÎïÅ©Òµ(ת»ùÒò×÷Îï¡¢ÁÖÒµºÍÓæÒµ)¡¢ÉúÎ。¿µ²úÒµ(ÉúÎïÖÆÒ©¡¢Ð·Ö×ÓʵÌå¡¢ÉúÎï±êÖ¾ÎïºÍ»ùÒò¼ì²â)ÒÔ¼°ÉúÎ﹤ҵ(ÉúÎïȼÁÏ¡¢ÉúÎﻯѧƷ¡¢Ô­ÁÏÉú²ú¹¤ÒµÓÃø¡¢ÉúÎï´«¸ÐÆ÷¡¢ÉúÎïÐÞ¸´¡¢×ÊÔ´ÌáÈ¡ºÍÉúÎᆱÁ¶)£»2014Ä꣬¾­¼ÃºÏ×÷Óë·¢Õ¹×éÖ¯(OECD)È·¶¨ÁËÉúÎï»ù²úÆ·ÖеÄ3¸öÖ÷Òª·ÖÖ§£ºÉúÎïȼÁÏ¡¢ÉúÎï»ù»¯Ñ§Æ·ÒÔ¼°ÉúÎïËÜÁÏ(ºóÁ½Õßͨ³£ºÏ³ÆΪÉúÎï»ù²ÄÁÏ)[4]¡£ÐÂÐ˵ÄÉúÎï²úÒµ°üÀ¨ÉúÎïÒ½Ò©¡¢ÉúÎﻯѧƷ¡¢ÉúÎïÄÜÔ´ºÍת»ùÒò×÷Îï²úÒµ[5-6]£¬ËüÃÇÊÇÈ«Çò×îÇ°ÑصÄÏÂÒ»´úÉúÎï¼¼Êõ²úÒµ£¬Ô¤¼ÆÔÚδÀ´½«µÃµ½¿ìËÙ·¢Õ¹¡£
ÎÒ¹úÕþ¸®Í¬ÑùÖØÊÓÉúÎï²úÒµµÄ·¢Õ¹£¬2016Ä꣬¹úÎñÔºÓ¡·¢ÁË¡¶¡°Ê®ÈýÎ塱¹ú¼Ò¿Æ¼¼´´Ð¹滮¡·[7]£¬Ìá³ö·¢Õ¹ÏȽø¸ßЧÉúÎï¼¼Êõ£¬Öص㲿ÊðÇ°ÑØÉúÎï¼¼ÊõµÄ´´ÐÂÍ»ÆƺÍÓ¦Ó÷¢Õ¹£»2017Ä꣬¹ú¼Ò·¢Õ¹¸Ä¸ïίӡ·¢ÁË¡¶¡°Ê®ÈýÎ塱ÉúÎï²úÒµ·¢Õ¹¹æ»®¡·[8]£¬½øÒ»²½Ìá³öÁËÉúÎï²úÒµ·¢Õ¹µÄ¾ßÌå¹æ»®¡£Òò´Ë̽¾¿ÖйúÔÚÈ«ÇòÉúÎï²úÒµÑо¿Öеķ¢Õ¹¶¨Î»¶ÔÓÚÖ¸µ¼ÎÒ¹úÉúÎï²úÒµ¸ßÖÊÁ¿·¢Õ¹¡¢½øÒ»²½ËõС·¢Õ¹²î¾à¾ßÓÐÖØÒªÒâÒå¡£
±¾ÎÄ·ÖÎöÁËÈ«ÇòÉúÎï²úÒµ·¢Õ¹µÄ»ù±¾ÏÖ×´¼°Æäʱ¿Õ¹æÂÉ£¬Ö¸³öÁËÉúÎï²úÒµ·¢Õ¹µÄÖ÷ÒªÌص㣬×îºó»ùÓÚÈ«ÇòÉúÎï²úÒµ·¢Õ¹µÄÏÖ×´ºÍÌصã´Ó5¸ö·½ÃæÌá³öÁËÖ¸µ¼ÎÒ¹úÉúÎï²úÒµ·¢Õ¹µÄÕþ²ß½¨Òé¡£
1 È«ÇòÉúÎï²úÒµ·¢Õ¹ÏÖ×´1.1 ÉúÎï²úÒµ·¢Õ¹µÄʱ¼äÌØÕ÷·ÖÎö½üÄêÀ´£¬È«ÇòÉúÎï²úÒµ¹æģʼÖÕ±£³ÖÒÔ½Ó½üGDPƽ¾ùÔöËÙ2±¶µÄËÙ¶ÈÔö³¤¡£¾Ý¹À¼Æ£¬ÒÔÉúÎï¼¼ÊõΪ»ù´¡µÄ²úÆ·ÏúÊÛ¶îÔÚ30ÄêÄÚ½«³¬¹ý15ÍòÒÚÃÀÔª£¬´Ó¶ø³ÉΪ¾­¼Ã·¢Õ¹µÄÖØÒªÇý¶¯Á¦[9]¡£ÔÚÉúÎïÒ½Ò©ÁìÓò£¬´Ó2012Äêµ½2017Ä꣬ȫÇòÒ½Ò©Êг¡µÄÄê¾ù¸´ºÏÔö³¤ÂÊԼΪ3.2%£¬2018ÄêÈ«ÇòÒ½Ò©Êг¡¹æģΪ1.63ÍòÒÚÃÀÔª£¬ÔöËÙΪ4.8%£»ÔÚת»ùÒò×÷Îï²úÒµ£¬È«Çòת»ùÒò×÷ÎïÖÖÖ²Ãæ»ýÓÉ1996ÄêµÄ170Íòhm2£¬µ½2006ÄêÍ»ÆÆ1ÒÚhm2£¬ÔÙµ½2018ÄêµÄ1.917ÒÚhm2[10]£¬¼¤ÔöÁËÔ¼112±¶£»ÔÚÉúÎï»ù»¯Ñ§Æ··½Ã棬OECDÌá³öÁ˵½2030Ä꽫»áÓдóÔ¼35%µÄ»¯Ñ§Æ·ÓÉÉúÎï»ù»¯Ñ§Æ·Ìæ´ú[11]£»ÔÚÉúÎïÄÜÔ´·½Ã棬¾Ý¹ú¼Ê¿ÉÔÙÉúÄÜÔ´»ú¹¹(IRENA)µÄͳ¼ÆÊý¾ÝÏÔʾ£¬2017ÄêÈ«ÇòÉúÎïÖÊÄÜ·¢µçÁ¿´ïµ½1.78 EJ£¬Ïà½ÏÓÚ2010ÄêµÄ1.14 EJÔö³¤56%¡£
1.2 ÉúÎï²úÒµ·¢Õ¹µÄ¿Õ¼äÌØÕ÷·ÖÎöÉúÎï²úÒµÊÇÒ»¸ö¸ß¸½¼ÓÖµ¡¢ÐÂÐ˵ļ¼ÊõÍƶ¯ÐͲúÒµ[12]£¬ÆäÊг¡×¼ÈëÃż÷½Ï¸ß¡£Ò»°ã¶øÑÔ£¬¾­¼Ã·¢Õ¹³Ì¶È½ÏºÃµÄ¹ú¼ÒÓÉÓھ߱¸½Ï¸ßµÄÉúÎï¿Æ¼¼Ë®Æ½¡¢¼áʵµÄÑз¢»ù´¡¡¢³ÉÊìµÄ×ʱ¾Êг¡ÒÔ¼°ÏȽøµÄ¹ÜÀíÄÜÁ¦£¬ÆäÍùÍù´¦ÓÚÈ«ÇòÉúÎï²úÒµ¼ÛÖµÁ´µÄÓÅÊƵØ룬ÆäÉúÎï²úÒµ·¢Õ¹×´¿ö½ÏºÃ£¬¶øÐÂÐ˾­¼ÃÌåÍùÍù´¦ÓÚÈõÊƵØ룬ÕâÔì³ÉÁËÈ«ÇòÉúÎï²úÒµ·¢Õ¹µÄ¿Õ¼ä·Ö²¼²»¾ùºâ£¬Òò´Ë·ÖÎöÈ«ÇòÉúÎï²úÒµ·¢Õ¹ÏÖ×´µÄ¿Õ¼äÌØÕ÷¶ÔÈÏÇåÎÒ¹úÉúÎï²úÒµ·¢Õ¹µÄÈ«Çò¶¨Î»ÊÇÊ®·Ö±ØÒªµÄ¡£
1.2.1 ÉúÎïÒ½Ò©²úÒµ»¯Ñ§ºÏ³ÉÒ©ÊÇÖÆÒ©ÐÐÒµµÄ´«Í³²úÆ·£¬ÔÚÈ«ÇòÒ©ÎïÉú²úÖÐÕ¼¾ÝÖ÷ÌåµØλ¡£È»¶ø½üÄêÀ´£¬Ëæ×ÅÉúÎïÖÆÒ©¼¼ÊõµÄ½ø²½£¬ÒÔÉúÎïÀàËÆҩΪ´ú±íµÄÉúÎï¼¼ÊõÒ©ÎïÒì¾üÍ»Æð¡£ÎÒ¹ú¶ÔÉúÎïÀàËÆÒ©µÄ¶¨ÒåÊÇÔÚÖÊÁ¿¡¢°²È«ÐÔºÍÓÐЧÐÔ·½ÃæÓëÒÑ»ñ×¼×¢²áµÄÔ­ÑÐÒ©¾ßÓÐÏàËÆÐÔµÄÖÎÁÆÓÃÉúÎïÖÆÆ·¡£ÉúÎïÖƼÁÓÈÆäÊÇÖØ×éµ¥¿Ë¡¿¹Ì塢ϸ°ûÒò×ÓµÈÔÚÖ×Áö¡¢×ÔÉíÃâÒßÐÔ¼²²¡µÈÖÎÁÆÁìÓòÖÐÕ¹ÏÖ³öÆäËûÒ©ÎïÎÞ·¨Ìæ´úµÄÍ»³öÁÙ´²ÁÆЧ¡£½ØÖÁ2017Ä꣬ÉúÎï¼¼ÊõÒ©ÎïÔÚÈ«ÇòÔÚÑÐÐÂÒ©ÖеıÈÀý´ïµ½38%£¬Ïà½ÏÓÚ2016ÄêÉÏÕÇÁË5¸ö°Ù·Öµã£¬¿É¼ûÉúÎï¼¼ÊõÒ©Îï·¢Õ¹ÊÆÍ·Ç¿¾¢£¬ÓÐÍû³ÉΪδÀ´Ò½Ò©²úÒµµÄ·¢Õ¹Öص㡣¸ù¾Ý¿Æî£Î¨°²¹«Ë¾µÄÑо¿±¨¸æÏÔʾ£¬½ØÖÁ2019ÄêÈ«Çò¸÷¹ú¼ÒºÍµØÇøÉúÎïÀàËÆÒ©µÄÑз¢¹ÜÏßÊýÁ¿Èçͼ 1Ëùʾ£¬´ÓͼÖпÉÒÔ¿´³öÖйúÒÔ298¸öµÄ×ÜÑз¢¹ÜÏßÊýÁ¿ÁìÏÈÈ«Çò£¬ÕâÒ»Êý×ÖÔ¼ÊÇÅÅÃûµÚ¶þµÄÅ·Ã˵ÄÁ½±¶(147¸ö)£¬ÃÀ¹úÅÅÃûµÚÈý(141¸ö)£¬Ó¡¶È¡¢º«¹ú¡¢ÈÕ±¾¡¢¶íÂÞ˹½ôËæÆäºó£¬¹ÜÏßÊýÁ¿·Ö±ðΪ129¡¢96¡¢50¡¢48¸ö£¬Õâ͹ÏÔÁËÎÒ¹úÔÚÉúÎï¼¼ÊõÒ©Îï²úÒµµÄÑз¢ÓÅÊÆ¡£µ«ÖµµÃ×¢ÒâµÄÊÇ£¬ÎÒ¹ú»ñµÃÅú×¼ÉÏÊеÄÉúÎïÀàËÆÒ©ÊýÁ¿½öÅÅÃûµÚÁù£¬ÓëÅ·ÃÀµÈ·¢´ï¹ú¼ÒÏà±ÈÈÔÓнϴó²î¾à£¬Õâ·´Ó³ÁËÎÒ¹úÉúÎïÀàËÆÎï²úÒµµÄͶÈë²ú³öЧÂÊÓдý½øÒ»²½¼ÓÇ¿¡£
ͼ 1 2019ÄêÊÀ½ç¸÷¹ú¼ÒºÍµØÇøÉúÎïÀàËÆÒ©¹ÜÏßÊýÁ¿ Fig. 1 Number of biosimilar drug pipelines in countries and regions of the world in 2019.
ͼѡÏî




1.2.2 ת»ùÒò×÷ÎïÖÖÖ²²úÒµ¸ù¾Ý¹ú¼ÊÅ©ÒµÉúÎï¼¼ÊõÓ¦Ó÷þÎñ×éÖ¯(ISAAA) 2018Äê·¢²¼µÄÊý¾Ý[13]ÏÔʾ£¬½ØÖÁ2017Ä꣬¹²ÓÐ24¸ö¹ú¼ÒÖÖÖ²ÁËת»ùÒò×÷Îï(Genetically modified crops, GM crops)£¬ÆäÖÐÓÐ18¸ö¹ú¼ÒµÄÖÖÖ²Ãæ»ý³¬¹ýÁË5Íòhm2£¬ÕâЩ¹ú¼ÒÖ÷Òª·Ö²¼ÔÚÃÀÖÞ¡¢¶«ÄÏÑÇÒÔ¼°Å·Ö޺ͷÇÖ޵IJ¿·ÖµØÇø¡£ÆäÖÐÃÀ¹úÒÔ7 500Íòhm2µÄÖÖÖ²Ãæ»ýÕ¼µ½ÊÀ½çת»ùÒò×÷ÎïÖÖÖ²×ÜÃæ»ýµÄ40%£¬Î»¾ÓÊÀ½çµÚÒ»¡£¶øÖйúµÄÖÖÖ²Ãæ»ýΪ280Íòhm2£¬½öÕ¼ÊÀ½çת»ùÒò×÷ÎïÖÖÖ²×ÜÃæ»ýµÄ1.5%¡£
1.2.3 ÉúÎïÄÜÔ´²úÒµÉúÎïÄÜÔ´ÊÇ×î´óµÄ¿ÉÔÙÉúÄÜÔ´£¬Õ¼¿ÉÔÙÉúÄÜÔ´¹©Ó¦µÄ2/3ÒÔÉÏ¡£ÉúÎïÖÊ×ÊÔ´µÄµäÐÍ·ÖÀà°üÀ¨³ÇÊÐÀ¬»ø¡¢¹¤Òµ·ÏÎï¡¢³õ¼¶¹ÌÌåÉúÎïȼÁÏ¡¢ÕÓÆøºÍÒºÌåÉúÎïȼÁÏ¡£¸ù¾ÝÊÀ½çÉúÎïÄÜԴЭ»á(WBA)ÔÚ2019Äê·¢²¼µÄͳ¼ÆÊý¾Ý[14]»æÖÆÁËÈ«ÇòÉúÎïÄÜÔ´²úÁ¿·Ö²¼Í¼(ͼ 2)¡£ÔÚ¸÷´óÖÞÖУ¬ÑÇÖÞÉúÎïÄÜÔ´²úÁ¿×î¸ß£¬Æä´ÎÊÇ·ÇÖÞºÍÃÀÖÞ¡£ÓÉÓÚн²ÄºÍľ̿¹ã·ºÓÃÓÚȡůºÍÅëâ¿£¬ÉúÎïÖÊÄÜÔ´ÔÚÑÇÖ޺ͷÇÖÞµÄÉúÎïÄÜÔ´¹©Ó¦ÖÐËùÕ¼±ÈÀý¶¼ºÜ¸ß¡£ÔÚÒºÌåÉúÎïȼÁÏ·½Ã棬ÃÀÖÞ(ÃÀ¹úºÍ°ÍÎ÷)ËùÕ¼·Ý¶î×î¸ß£¬Ô­Òò·Ö±ðÊÇÓÉÓñÃ׺͸ÊÕáÉú²úµÄÉúÎïÒÒ´¼²úÁ¿½Ï¸ß£¬Í¬Ê±£¬¸ÃµØÇøռȫÇòÉúÎïȼÁϹ©Ó¦µÄ70%ÒÔÉÏ¡£Å·ÖÞÔÚÕÓÆø¹©Ó¦·½Ãæ´¦ÓÚÁìÏȵØ룬ÒòΪËüռȫÇò¹©Ó¦Á¿µÄ50%ÒÔÉÏ¡£ÓÉÓÚ·ÙÉÕ¡¢Æø»¯µÈÀ¬»ø·ÙÉÕ·¢µç¼¼ÊõµÄ¹ã·ºÓ¦Óã¬Å·ÖÞ³ÇÊÐÀ¬»ø²úÉúµÄÉúÎïÄÜÔ´¹©Ó¦Á¿Ò²¾ÓÊÀ½çÊ×λ£¬Õ¼È«Çò¹©Ó¦Á¿µÄ2/3¡£
ͼ 2 2017ÄêÈ«ÇòÉúÎïÄÜÔ´²úÁ¿·Ö²¼ Fig. 2 Supply of global bioenergy production in 2017.
ͼѡÏî




1.2.4 ÉúÎï»ù»¯Ñ§Æ·²úÒµÓ봫ͳ»¯Ñ§²úÆ·Ïà±È£¬ÉúÎï»ù»¯Ñ§Æ·µÄ»·¾³×ã¼£ÓÐÏÞ£¬ÔÚ´Ù½ø¿É³ÖÐø·¢Õ¹ºÍ¸ÄÉÆÆøºò±ä»¯·½Ãæ·¢»ÓÖØÒª×÷ÓÃ[15]¡£Ä¿Ç°È«ÇòÉúÎï»ù»¯Ñ§Æ·ÉÌÒµ»¯·¢Õ¹µÄÈȵã°üÀ¨ÉúÎïËÜÁÏ¡¢ÉúÎï»ùçúçêËá¡¢ÉúÎï»ù¶¡´¼¡¢ÉúÎï²ñÓÍ¡¢ÉúÎï»ù¸ÊÓͼ°ÆäÑÜÉúÎïÒÔ¼°ÉúÎïÒìÎì¶þÏ©ÓëÉúÎïÏ𽺡£¶øרÀûÉêÇëÊýÁ¿ÔòÊÇ·´Ó³ÉúÎï»ù»¯Ñ§Æ·²úÒµ·¢Õ¹×´¿öµÄÖØÒªÖ¸±ê£¬Òò´Ë±¾ÎÄͨ¹ý¶ÔÊÀ½ç֪ʶ²úȨ×éÖ¯(WIPO)µÄÔÚÏßÊý¾Ý¿âµÄרÀûÊý¾Ý½øÐмìË÷£¬µÃµ½ÁËÉÏÊöÈ«ÇòÉúÎï»ù»¯Ñ§Æ·Ïà¹ØרÀûµÄÈ«Çò·Ö²¼Çé¿ö(±í 1)¡£´Ó¸÷ÉúÎï»ù»¯Ñ§Æ·µÄרÀû×ÜÁ¿À´¿´£¬ÉúÎïËÜÁÏÏà¹ØרÀûµÄÊýÁ¿×î¶à(33.7%)£¬Æä´ÎÊÇÉúÎï»ù¸ÊÓÍ(30.3%)ºÍÉúÎï»ùçúçêËá(16.5%)£»´Ó¸÷ÉúÎï»ù»¯Ñ§Æ·×¨ÀûËùÊô¹ú¼Ò(¾­¼ÃÌå)À´¿´£¬ÃÀ¹úÒÔѹµ¹ÐÔµÄÓÅÊÆÕ¼¾ÝµÚÒ»Ãû£¬½ô½Ó×ÅÊÇÅ·ÃË¡¢°Ä´óÀûÑǺͼÓÄô󣬶øÖйúµÄרÀû×ÜÁ¿½öΪ330¼þ£¬ÓëÆäËû¹ú¼Ò(¾­¼ÃÌå)Ïà±È´æÔںܴó²î¾à¡£
±í 1 È«ÇòÖ÷ÒªÉúÎï»ù»¯Ñ§Æ·Ïà¹ØרÀûÊýÁ¿Table 1 Number of patents related to major bio-based chemicals
Country (economy union) Bioplastic Bio-based succinic acid Bio-based butanol Bio-based diesel Bio-based glycerin Bio-based isoprene Bio-based rubber Total
US 106 727 46 545 20 179 6 077 88 354 4 825 28 215 300 922
EU 22 933 12 479 5 736 1 444 22 609 1 396 6 508 73 105
Australia 20 232 11 928 4 622 1 262 21 390 857 5 148 65 439
Canada 19 034 10 863 4 244 1 135 19 194 826 4 829 60 125
New Zealand 2 007 1 458 565 59 2 380 52 503 7 024
Israel 1 856 1 300 624 62 1 998 51 472 6 363
UK 1 318 439 393 141 647 52 476 3 466
South Africa 1 131 899 415 28 1 434 39 305 4 251
China 183 NA 34 41 NA 8 64 330
Total 175 421 85 911 36 812 10 249 158 006 8 106 46 520 521 025
Note: ¡°NA¡± indicates data is missing.

±íÑ¡Ïî


2 È«ÇòÉúÎï²úÒµ·¢Õ¹Ìصã2.1 ¿Æ¼¼´´ÐÂËٶȼӿìÉúÎï²úÒµÊǼ¼ÊõÃܼ¯Ð͵ĸ߶˿Ƽ¼²úÒµ£¬¶Ô¼¼Êõ´´ÐµÄÒªÇó¸ß£¬Ö»ÓÐÕÆÎÕºËÐÄÉúÎï¿Æ¼¼£¬²ÅÄÜÔÚÈ«ÇòÉúÎï²úÒµ¼ÛÖµÁ´ÖÐÕ¼¾ÝÖ÷µ¼µØλ¡£Ò»·½Ã棬ÉúÎï¿ÆѧµÄµß¸²ÐÔ´´ÐÂÕýÔÚÇý¶¯×ÅÉúÎï¼¼ÊõºÍÉúÎï²úÒµµÄ¿ìËÙ·¢Õ¹¡£
ÉúÎïÒ½Ò©·½Ã棬·Ö×ÓÉúÎïѧ¡¢»ùÒò×éѧ¡¢µ°°×ÖÊ×éѧµÈÉúÃü¿Æѧ²»¶ÏÍ»ÆÆ£¬´Ù½øÁËÒ©ÎïµÝËÍ¡¢µ¥·Ö×Ó²âÐò¡¢µ°°×Öʹ¤³ÌµÈÉúÎï¼¼ÊõµÄ½ø²½£¬½ø¶øÇý¶¯ÁËÒ©ÎïÑз¢¡¢¸ßЧ»ùÒò²âÐòƽ̨¡¢CAR-T¡¢Èںϵ°°×µÈ²úÒµÁìÓòµÄ·¢Õ¹£»ÁíÒ»·½Ã棬´«Í³ÉúÃü¿ÆѧÁìÓòÕýÔÚÓë°üÀ¨3D´òÓ¡¡¢È˹¤ÖÇÄÜ¡¢ÔƼÆËã¡¢´óÊý¾Ý¡¢ÎïÁªÍø¡¢Çø¿éÁ´¡¢ÖÇÄÜÖÆÔì¡¢»úÆ÷È˵ÈÔÚÄÚµÄм¼Êõ½»²æÈںϣ¬¿ªÍØÁËÔÙÉúÒ½ÁÆ¡¢Êý×ÖÒ½ÁÆ¡¢ÖÇ»ÛÒ½ÁƵȲúÒµ£¬ÎªÎ´À´ÉúÎïÒ½Ò©²úÒµ·¢Õ¹ÌṩÁ˹ãÀ«Ç°¾°¡£
ת»ùÒò×÷ÎïÖÖÖ²²úÒµ·½Ã棬ͬʱ¾ß±¸¿¹Äæ¡¢¿¹³æ¡¢¿¹³ý²Ý¼ÁµÄ¸´ºÏÐÔ״ת»ùÒòÅ©×÷ÎïÖÖ×Ó³ÉΪÑз¢Èȵ㲢ÕýÔڵõ½ÍƹãÓ¦Ó㬴ËÍ⣬µÚ¶þ´úת»ùÒò×÷ÎïÒÔ»ùÒò¹¤³Ì£¬ÌرðÊÇÖ²Îï´úл¹¤³ÌΪ»ù´¡£¬Öصã¸ÄÁ¼Á˲úÆ·Æ·ÖÊ¡¢Ôö¼ÓÓªÑø¡¢Ìá¸ßʳƷµÄÒ½ÁƱ£½¡¹¦ÄÜ£¬»òÓÃÓÚ¹¤ÒµÔ­ÁÏ£¬Ôö¼ÓÅ©¸±²úÆ·µÄ¸½¼ÓÖµ¡£
ÉúÎï»ù»¯Ñ§Æ·²úÒµ·½Ã棬΢ÉúÎøµÈ׿ԽÉúÎï´ß»¯¼ÁµÄ¹¦ÄÜÑз¢Óë¸Ä½ø¸ü¼ÓÖÇÄܸßЧ£¬ÓÐÍû´øÀ´»¯Ñ§Æ·ºÍ²ÄÁÏÂÌÉ«ÖÆÔìµÄбä¸ï¡£
ÉúÎïÄÜÔ´²úÒµ·½Ã棬ÈËÀ಻¶ÏÔÚ̽Ë÷ÐÂÐÍÉúÎïÖÊÄÜÔ´ÒÔ¼°Ìá¸ßÉúÎïÄÜԴת»¯Âʵķ½·¨£¬ÒÔÆÚÔÚδÀ´ÍêÈ«Ìæ´ú»¯Ê¯ÄÜÔ´£¬ÊµÏÖÂÌÉ«·¢Õ¹¡£
2.2 Ñз¢Í¶ÈëÁ¦¶ÈÔöǿΪӦ¶ÔÈÕÇ÷¼¤ÁҵĹú¼ÊÒ½Ò©²úÒµ¾ºÕù¾ÖÊÆ£¬È«Çò¸÷´óÉúÎïÒ½Ò©ÆóÒµÕùÏà¼Ó´ó¿ÆÑÐͶÈë¡£´ÓÅ·ÃËίԱ»áÔÚ2017ÄêºÍ2019Ä깫²¼µÄ¡¶È«Çò²úÒµÑз¢Í¶È뱨¸æ¡·[16-17]ÖзֱðÑ¡È¡Á˵±ÄêÈ«ÇòÑз¢Í¶ÈëÕ¼±È×î¸ßµÄ10¼ÒÉúÎï¼¼Êõ¹«Ë¾Èç±í 2Ëùʾ¡£´ÓÉÏ°ñÆóÒµµÄÑз¢Õ¼±ÈÀ´¿´£¬ÉúÎï¼¼Êõ¹«Ë¾µÄÑз¢Í¶ÈëÆÕ±éÆ«¸ß£¬2017ÄêµÄƽ¾ùÑз¢Õ¼±ÈΪ27.5%£¬2019ÄêµÄΪ29.1%£¬¶ø2017ÄêºÍ2019ÄêÈ«ÇòÆäËûÐÐÒµÑз¢Í¶ÈëÕ¼±È×î¸ßµÄÇ°10¼Ò¹«Ë¾µÄƽ¾ùÑз¢Í¶Èë·Ö±ðΪ23.4%ºÍ25.4%£¬¾ùµÍÓÚÉúÎï¼¼ÊõÆóÒµ£¬Õâ͹ÏÔÁËÉúÎï¼¼ÊõÆóÒµÑз¢Í¶ÈëÇ¿¶È½Ï¸ßµÄÌص㣻´ÓÉÏ°ñÆóÒµµÄ¹ú¼Ò·Ö²¼À´¿´£¬¿ÉÒÔ¿´³öÃÀ¹ú¡¢Å·ÖÞºÍÈÕ±¾µÄÉúÎï¼¼ÊõÆóÒµ¸ü×¢ÖØÑз¢Í¶È룬¶øĿǰûÓÐÖйúÆóÒµÉÏ°ñ£¬Õâ±íÏÖÁËÖйúÆóÒµÑз¢Í¶Èë²»¸ßµÄÎÊÌ⣻´Ó¸÷ÉÏ°ñÆóÒµµÄºáÏò¶Ô±ÈÀ´¿´£¬¿ÉÒÔ·¢ÏÖÑз¢Í¶ÈëÕ¼±È½Ï¸ßµÄÆóÒµÆÕ±éÑз¢Í¶Èë½ð¶î²»¸ß£¬¼´ÆóÒµ¹æÄ£²»¸ß£¬ÕâÌåÏÖ³öÖÐСÉúÎïÆóÒµ¸ü×¢ÖØÑз¢Í¶ÈëÒÔÆÚÔÚÊг¡¼¼Êõ¸ïÐÂÖÐÕ¼¾ÝÓÅÊÆ£»´ÓÉÏ°ñÆóÒµµÄʱ¼ä±ä»¯ÌØÕ÷À´¿´£¬Æ½¾ùÑз¢Í¶ÈëÕ¼±È´Ó2017ÄêµÄ27.5%Ôö³¤µ½2019ÄêµÄ29.1%£¬³ÊÏÖ³öÑз¢Í¶ÈëÈȶÈÉÏÉýÇ÷ÊÆ¡£
±í 2 2017ºÍ2019ÄêÈ«ÇòÉúÎï¼¼Êõ¹«Ë¾Ñз¢Ç¿¶ÈÅÅÃûTable 2 Ranking of global biotech companies by R & D intensity in 2017 and 2019
Ranking 2017 2019
Company Country R & D (€bn) R & D int. (%) Company Country R & D (€bn) R & D int. (%)
1 Vertex Pharma US 1.01 62.5 Incyte US 1.03 62.6
2 Celgene US 4.24 39.8 Vertex Pharma US 1.23 46.2
3 Bristol-Myers Squibb US 4.60 24.9 Celgene US 3.97 28.8
4 AstraZeneca UK 5.36 24.6 Bristol-Myers Squibb Belgium 1.13 25.5
5 Daiichi Sankyo Japan 1.74 22.4 UCB UK 4.63 24.0
6 Boehringer Sohn Germany 3.11 21.0 AstraZeneca US 8.46 22.9
7 Eli Lilly US 4.18 20.8 Merck Japan 1.61 21.9
8 Takeda Pharma Japan 2.73 20.1 Daiichi Sankyo Japan 1.01 20.0
9 Roche Switzerland 9.24 19.6 Eisai Switzerland 9.80 19.4
10 Allergan Ireland 2.68 19.4 Roche US 2.27 19.3
Average 3.89 27.5 Average 3.51 29.1

±íÑ¡Ïî


2.3 ×ʱ¾Êг¡ÐèÇó¶È¸ßÉúÎï²úÒµÓÈÆäÊÇÉúÎïÒ½Ò©²úÒµ´æÔÚ×ÅÑз¢×ʽðÁ¿´ó¡¢²úÆ·Ñз¢ÖÜÆÚ³¤¡¢¼¼Êõ´´Ð³ɹ¦Âʵ͵ÈÌص㣬µ¼ÖÂÆä¶Ô×ʱ¾Êг¡µÄÐèÇó¶È½Ï¸ß¡£´Ó´óÐÍÉúÎïÉú¼¼¹«Ë¾µÄÉÏÊÐÇé¿öÀ´¿´£¬¸ù¾Ý°²ÓÀ»á¼ÆʦÊÂÎñËù(Ernst & Young)µÄÊý¾ÝÏÔʾ£¬2014Ä꣬¼´ÉÏÒ»¸ö¸ß·å£¬ÓÐ88¼ÒÉúÎï¼¼Êõ¹«Ë¾³ï¼¯ÁË63ÒÚÃÀÔªµÄIPO×ʽ𡣶ø2018Ä꣬¹²ÓÐ71¼ÒÉúÎï¼¼Êõ¹«Ë¾ÉÏÊУ¬Ä¼×Ê×ܶî¸ß´ï83ÒÚÃÀÔª£¬Ô¶³¬2014Äê[18]¡£2018ÄêÉúÎï¼¼ÊõIPOƽ¾ùÿ±Êļ¼¯×ʽ𳬹ý1.16ÒÚÃÀÔª£¬¶ø2014ÄêµÄ¾ùֵΪ7 300ÍòÃÀÔª£¬ÔöÕÇÁË4 300ÍòÃÀÔª[18]¡£´ÓÖÐСÐÍÉú¼¼¹«Ë¾µÄÈÚ×ÊÇé¿öÀ´¿´£¬·çÏÕͶ×ʳÉΪÆäÈÚ×ʵÄÖØÒªÇþµÀ£¬ÒÔÃÀ¹úΪÀý£¬Æä·¢´ïµÄ·çÏÕͶ×Êģʽ¶Ô°üº¬ÉúÎï²úÒµÔÚÄڵĸßм¼Êõ²úÒµ·¢Õ¹¾ßÓÐÃ÷ÏԵĴٽø×÷ÓÃ[19]£¬ÖµµÃÎÒ¹ú½è¼ø¡£¸ù¾ÝÓ¢¹úÉúÎï²úҵЭ»á(BIA)ÔÚ2020Äê1Ô·¢²¼µÄÉúÎï²úÒµÈÚ×ÊÇé¿ö·ÖÎö±¨¸æ[20]ÏÔʾ£¬2019ÄêÃÀ¹úÉúÎï¼¼Êõ²úÒµµÄ·çÏÕͶ×Ê×ܶî¸ß´ï95ÒÚÓ¢°÷£¬¾ÓÊÀ½çµÚÒ»£¬Æä´ÎÊÇÅ·ÖÞ(26ÒÚÓ¢°÷)£¬ÖйúλÓÚµÚÈý£¬Æä·çÏÕͶ×ʶîΪ20ÒÚÓ¢°÷£¬¿ÉÒÔ¿´³öÖйúÉúÎï²úÒµµÄ·çÏÕ×ʱ¾½»Ò×Êг¡ÓëÃÀ¹úÈÔÓнϴó²î¾à¡£
2.4 ²úÒµ¾Û¼¯ÏÖÏóÃ÷ÏÔµ±Ç°È«ÇòÉúÎï²úÒµ¼¯ÈºÏòן߶Ⱦۼ¯»¯·¢Õ¹£¬Ä¿Ç°ÃÀ¹úÒÑÐγÉÁ˾ɽðɽ¡¢²¨Ê¿¶Ù¡¢»ªÊ¢¶Ù¡¢±±¿¨ÂÞÀ³ÄÉ¡¢Ê¥µØÑǸçÎå´óÉúÎï¼¼Êõ²úÒµ¼¯¾ÛÇø[21]£»Ó¢¹ú½£ÇſƼ¼Ô°¡¢·¨¹úÀï°ºÉúÎï¼¼ÊõÔ°¡¢Ð¼ÓÆÂÆô°ÂÉúÃü¿Æѧ԰¡¢ÈÕ±¾Éñ»§²úÒµÔ°ÇøµÈÉúÎï¼¼Êõ²úÒµÔ°Çø¶¼¾Û¼¯ÁËÖÚ¶àÉúÎï¼¼Êõ¹«Ë¾£»ÎÒ¹úÒ²½¨Á¢ÁË°üÀ¨±±¾©¡¢ÉϺ£¡¢¹ãÖÝ¡¢ÉîÛÚ¡¢Ê¯¼Òׯ¡¢³¤´º¡¢Çൺ¡¢³¤É³¡¢Î人¡¢À¥Ã÷¡¢ÖØÇìºÍ³É¶¼ÔÚÄÚµÄ12¸ö¹ú¼ÒÉúÎï²úÒµ»ùµØ¡£²úÒµ¾Û¼¯Äܹ»ÓÐЧ´Ù½ø¼¼Êõ´´Ð£¬Ôö¼Ó×ʽð¡¢È˲š¢Îï×Ê¡¢¼¼ÊõºÍ¹ÜÀíµÄ¸ßЧ½»Á÷£¬ÓÐÀûÓÚÉúÎï²úÒµµÄ·¢Õ¹£¬³ÉΪÁËÄ¿Ç°È«ÇòÉúÎï²úÒµ·¢Õ¹µÄÌصãºÍÇ÷ÊÆÖ®Ò»¡£
3 ÎÒ¹úÉúÎï²úÒµµÄ·¢Õ¹Æ¿¾±¼°Õþ²ß½¨Òé3.1 Ìá¸ßÉúÎï¿Æѧ´´ÐÂˮƽ£¬´Ù½ø²úѧÑÐÉî¶ÈÈںϷ¢Õ¹ÎÒ¹úÉúÎï²úÒµµÄ´´ÐÂˮƽ½ÏµÍ£¬Ò»²¿·ÖÔ­ÒòÊÇ»ù´¡ÉúÎï¿ÆѧµÄÑо¿Ë®Æ½²»¸ß£¬ÌåÏÖÔÚÎÒ¹úÉúÎï¼¼ÊõÁìÓòÏà¹ØµÄÂÛÎÄ¡¢×¨ÀûµÈÑо¿³É¹ûÊýÁ¿ÓÐÏÞ£¬ÖÊÁ¿²Î²î²»Æ룬ÖØ´ó¿ÆÑгɹû²»×㣬ѧÊõÓ°ÏìÁ¦½ÏµÍ£»ÁíÒ»·½Ã棬ÉúÎï¼¼ÊõÁìÓòµÄÍ»ÆƲ»ÄܺܺõØÓ¦Óõ½Êµ¼ÊÉú²úÖÐÈ¥£¬´æÔÚÀíÂÛÓëʵ¼ùÍѽڵÄÎÊÌâ¡£»ùÓÚ´Ë£¬ÎÒ¹úÓ¦µ±Ìá¸ßÉúÎï¿Æѧ´´ÐÂˮƽ£¬¼ÓÇ¿»ù´¡ÉúÎï¿ÆѧÀíÂÛÑо¿£¬´Ù½øÉúÎï¿ÆѧÓëÆäËûÁìÓòµÄ½»²æÈںϣ¬¼á¶¨²»ÒÆ×ßÖйúÌØÉ«ÉúÎï²úÒµ×ÔÖ÷´´ÐµÀ·£¬ÅàÑø¾ßÓйú¼ÊÒ»Á÷ˮƽµÄÉúÎï¿Æ¼¼È˲źÍÍŶӣ¬½¨Éè¾ß±¸¹ú¼Ê¾ºÕùÁ¦µÄ¿ÆÑлú¹¹£¬¼Ó¿ìʵʩ´´ÐÂÇý¶¯·¢Õ¹Õ½ÂÔ£»Òª½øÒ»²½É¿Æ¼¼ÌåÖƸĸ½¨Á¢ÒÔÉúÎï¼¼ÊõÆóҵΪÖ÷Ìå¡¢ÉúÎï²úÒµÊг¡Îªµ¼Ïò¡¢²úѧÑÐÉî¶ÈÈںϵļ¼Êõ´´ÐÂÌåϵ£¬¼ÓÇ¿¶ÔÖÐСÆóÒµ´´ÐµÄÖ§³Ö£¬´Ù½ø¿Æ¼¼³É¹ûת»¯¡£
3.2 ÓÅ»¯ÉúÎï²úÒµ·¢Õ¹½á¹¹£¬¼Ó¿ìÉúÎï²úÒµ¸ßÖÊÁ¿·¢Õ¹ÎÒ¹úÉúÎï²úÒµµÄ·¢Õ¹½á¹¹²»ÉõºÏÀí£¬¸÷ϸ·Ö²úÒµ·¢Õ¹±ÈÀý²»Ð­µ÷¡¢¸÷µØÇøÉúÎï²úÒµ·¢Õ¹²»¾ùºâÏÖÏóÑÏÖØ£»ÉúÎï²úÒµ·¢Õ¹ÒÔÖÆÔì¼Ó¹¤ÎªÖ÷£¬ÔÚÈ«ÇòÉúÎï²úÒµ¼ÛÖµÁ´Öд¦ÓÚÈõÊƵØ룬ÉúÎï²úÒµÊг¡ÂúÒâ¶È½ÏµÍ£¬ÉúÎï¼¼Êõ²úÆ·ÖÊÁ¿²»¸ß¡£»ùÓÚ´Ë£¬ÎÒ¹úÓ¦µ±×ª»»ÉúÎï²úÒµ·¢Õ¹¶¯ÄÜ£¬ÊµÏÖÉúÎï²úÒµ·¢Õ¹ÓÉ×·ÇóÊýÁ¿¹æÄ£À©ÕÅÏò×·ÇóÖÊÁ¿Ð§ÂÊ·½Ïòת±ä£¬´Ù½øÉúÎï²úÒµ¸ßÖÊÁ¿·¢Õ¹£»Í³³ïÉúÎï²úÒµÇøÓòЭµ÷·¢Õ¹£¬ÊµÏÖÈ«¹úÉúÎï²úÒµÓÅÊÆ»¥²¹¡¢¹²Í¬·¢Õ¹µÄиñ¾Ö£»ÍƽøÉúÎï²úÒµ¹©¸ø²à½á¹¹ÐԸĸ´ÓÉúÎï¼¼Êõ²úÆ·Ïû·ÑÕß³ö·¢£¬Ìá¸ßÉúÎï²úÒµÊг¡ÂúÒâ¶È¡£
3.3 ¼ÓÇ¿ÉúÎï²úÒµ×ʽðÖ§³Ö£¬½¨Á¢ÊÊÓ¦ÏÖ´ú»¯ÉúÎï²úÒµÌصãµÄÈÚ×Ê»·¾³ÎÒ¹ú×÷ΪÊÀ½çÐÂÐ˾­¼ÃÌ壬×ʱ¾Êг¡³ÉÊì¶ÈÓëÅ·ÃÀµÈ·¢´ï¹ú¼ÒÏà±È´æÔÚÒ»¶¨²î¾à£¬¶øÑз¢·çÏսϸߵÄÉúÎï²úÒµÐèÒªÕþ¸®µÄ´óÁ¦Ö§³Ö£¬Õâµ¼ÖÂÎÒ¹úÖÐСÐÍÉúÎï¼¼ÊõÆóÒµÈÚ×ÊÀ§ÄÑ£¬²úÆ·Ñз¢ÄÑÒÔ¿ªÕ¹£¬´Ó¶øÏÞÖÆÁËÎÒ¹úÉúÎï²úÒµµÄ·¢Õ¹¡£Òò´ËÎÒ¹úÓ¦µ±¼Ó¿ì½¨Á¢ÏÖ´ú»¯µÄÉúÎï²úÒµÈÚ×Ê»·¾³£¬·¢Õ¹Ö¤È¯Êг¡ÈÚ×ʺͷçÏÕͶ×Ê[22]£¬²¢¹ÄÀøÉúÎï²úÒµÃñ¼äͶ×Ê£¬Îª³õ´´ÉúÎïÆóÒµºÍÖÐСÉúÎïÆóÒµÌṩͶÈÚ×ÊÖ§³ÖµÈÓÅ»ÝÕþ²ß£»Ó¦µ±ÔÊÐí°üÀ¨·ûºÏÌõ¼þµÄ¶¥¼¶Íâ¹ú»ú¹¹Í¶×ÊÕß¡¢Í¶×ÊÒøÐкÍ֤ȯ¹«Ë¾ÔÚÄÚµÄÖÚ¶àÊг¡²ÎÓëÕßÕ¹¿ª¹«Æ½¾ºÕù£»ÒªÓÅ»¯ÉúÎï¼¼Êõ¹«Ë¾ÉÏÊÐÖƶȣ¬Ìá¸ß²»ºÏ¸ñÆóÒµµÄÍËÊÐЧÂÊ£¬¹ÄÀøÉúÎï¼¼ÊõÆóÒµ¼ä²¢¹º¼°ÖªÊ¶²úȨתÒÆ£¬Í¨¹ý×ʱ¾Êг¡ÍêÉÆÉúÎï²úÒµ²úȨÖƶȺÍÒªËØ»¯Êг¡ÅäÖ㬳ä·Öµ÷¶¯ÉúÎï²úÒµÊг¡¾­¼Ã»îÁ¦£¬ÎªÎÒ¹úÉúÎï²úÒµ·¢Õ¹Ìṩ½ðÈÚÉú̬±£ÕÏ¡£
3.4 ·Å¿íÉúÎï¾­¼ÃÊг¡×¼È룬ÍêÉÆ¿ª·ÅÐÍÉúÎï¾­¼ÃÌåÖÆÎÒ¹úÔÚÉúÎï²úÒµÊг¡×¼Èë·½ÃæÃ÷ÏÔÂäºóÓÚÅ·ÃÀµÈ·¢´ï¹ú¼Ò£¬Ïà¹ØÕþ²ßºÍ»úÖƵIJ»ÍêÉÆÊÇÄ¿Ç°ÏÞÖÆÉúÎï²úÒµ·¢Õ¹µÄÕÏ°­Ö®Ò»¡£Õë¶ÔÕâÒ»ÎÊÌ⣬ÐèÒª´ÓÕþ²ß¹ÜÀí¶Ë×ÅÁ¦£ºÓ¦µ±½øÒ»²½Ö÷¶¯À©´óÉúÎï²úÒµ¶ÔÍ⿪·Å£¬½¡È«´Ù½ø¶ÔÍâÉúÎï²úҵͶ×ÊÕþ²ßºÍ·þÎñÌåϵ£¬ÍêÉÆÉúÎï²úÒµÉæÍ⾭ó·¨Âɺ͹æÔòÌåϵ£¬Ìá¸ß¹ú¼Ê»¯Êг¡¼à¹Ü͸Ã÷ÐÔ£»½øÒ»²½·Å¿íÊг¡×¼È룬ÎüÒý¸ü¶àÓÅÖÊÉúÎï¼¼ÊõÆóÒµºÍ²úÒµÔÚÎÒ¹úÉúÎï¾­¼ÃÊг¡ÉĮ̈ͬ¾ºÕù£»Í¬Ê±ÍØÕ¹ÉúÎï²úÒµ¶ÔÍâóÒס¢È˲Ž»Á÷¡¢¿Æ¼¼ºÏ×÷¡¢×ʽð»¥Í¨£¬ÍêÉÆÉúÎï²úÒµÒªËØÊг¡»¯ÅäÖã»Í¬Ê±·¢»ÓÎÒ¹úÖÆÔìÒµÓÅÊÆ£¬´óÁ¦Òý½øÏà¹Ø²úÒµÔÚÖйú·¢Õ¹£¬´òÔì¸ß¶ËÉúÎïÖÆÔì¡£
3.5 Ãé×¼ÉúÎï²úÒµ¹ú¼Ê±ê×¼£¬Ìá¸ßÉúÎï²úÒµ¹ú¼Ê¾ºÕùÁ¦ÎÒ¹úÄ¿Ç°ÔÚÉúÎïÖÆÒ©¡¢ÉúÎïÄÜÔ´¡¢ÉúÎïÅ©Òµ¡¢ÉúÎï»ù²ÄÁϵȷ½Ãæ´ó¶àûÓвÉÓù淶µÄ¹ú¼Ê±ê×¼£¬µ¼ÖÂÎÒ¹úÉúÎï¼¼Êõ²úÆ·¹ú¼ÊÈϿɶȻ¹²»¹»¸ß£¬ÉúÎï²úҵȱ·¦¹ú¼Ê¾ºÕùÁ¦£¬È±·¦ÊÀ½çÁúÍ·ÉúÎï¼¼Êõ¹«Ë¾Æ·ÅÆ¡£Õë¶ÔÕâÒ»ÎÊÌ⣬ÎÒ¹úÓ¦µ±»ý¼«Óë¹ú¼Ê½Ó¹ì£¬Ãé×¼ÉúÎï²úÒµ¹ú¼Ê±ê×¼£¬ÔÚ×ÛºÏÌá¸ßÉúÎï¿Æѧ´´ÐÂˮƽ¡¢ÓÅ»¯ÉúÎï²úÒµ·¢Õ¹½á¹¹¡¢¼ÓÇ¿ÉúÎï²úÒµ×ʽðÖ§³ÖÒÔ¼°·Å¿íÉúÎï¾­¼ÃÊг¡×¼ÈëµÈÕþ²ßµÄÒýÁìÏ£¬×ÅÁ¦´òÔì¾ß±¸È«Çò¾ºÕùÁ¦µÄÉúÎï²úÒµ¹ú¼ÊÆ·ÅÆÒÔ¼°È«ÇòÖªÃûµÄÉúÎï¼¼Êõ¹«Ë¾¡£
²Î¿¼ÎÄÏ×
[1] Davis S, Meyer C. What will replace the tech economy. Time, 2000, 155(21): 76-77.
[2] National bioeconomy blueprint[EB/OL].[2020-05-27]. https://obamawhitehouse.archives.gov/sites/default/files/microsites/ostp/national_bioeconomy_blueprint_april_2012.pdf.
[3] Innovating for sustainable growth: A bioeconomy for Europe[EB/OL]. (2012-02-13)[2020-05-27]. http://ec.europa.eu/research/bioeconomy/pdf/official-strategy_en.pdf.
[4] OE CD. Biobased chemicals and bioplastics: Finding the right policy balance. Paris: OECD Publishing, 2014, 2.
[5] Kolympiris C, Kalaitzandonakes N, Miller D. Location choice of academic entrepreneurs: Evidence from the US biotechnology industry. J Bus Vent, 2015, 30(2): 227-254.
[6] Ozan DC, Baran Y. Comparative development of knowledge-based bioeconomy in the European Union and Turkey. Crit Rev Biotechnol, 2014, 34(3): 269-280.
[7] "Ê®ÈýÎå"¹ú¼Ò¿Æ¼¼´´Ð¹滮[EB/OL].[2020-05-27]. http://www.gov.cn/zhengce/content/2016-08/08/content_5098072.htm.
[8] "Ê®ÈýÎå"ÉúÎï²úÒµ·¢Õ¹¹æ»®[EB/OL]. (2016-12-20)[2020-05-27]. https://www.ndrc.gov.cn/fggz/fzzlgh/gjjzxgh/201706/W020191104624250601539.pdf.
[9] Wang Y, Li PP, Zhang YP, et al. Current situation of global biotechnology input and output and China's strategies. China Sci Technol Resour Rev, 2018, 50(6): 30-34,100 (in Chinese).
ÍõÓ¨, ÀîƼƼ, ÕÅһƽ, µÈ. È«ÇòÉúÎï¼¼ÊõͶÈë²ú³öÏÖ×´·ÖÎö¼°¶Ô²ßÑо¿. Öйú¿Æ¼¼×ÊÔ´µ¼¿¯, 2018, 50(6): 30-34,100.
[10] ISAAA. Global status of commercialized biotech/GM crops in 2018. China Biotechnol, 2019, 39(8): 1-6 (in Chinese).
¹ú¼ÊÅ©ÒµÉúÎï¼¼ÊõÓ¦Ó÷þÎñ×éÖ¯. 2018ÄêÈ«ÇòÉúÎï¼¼Êõ/ת»ùÒò×÷ÎïÉÌÒµ»¯·¢Õ¹Ì¬ÊÆ. ÖйúÉúÎ﹤³ÌÔÓÖ¾, 2019, 39(8): 1-6.
[11] The bioeconomy to 2030: Designing a policy agenda[EB/OL].[2020-05-27]. http://www.oecd.org/futures/long-termtechnologicalsocietalchallenges/42837897.pdf.
[12] Zhang LX, Li WS, Bai JY, et al. Evaluating the international competitiveness for the biology industry of China based on AHP. Sci Technol Manag Res, 2010, 30(10): 32-34 (in Chinese).
ÕÅÁìÏÈ, ÀîΰÊé, °×¾©Óð, µÈ. »ùÓÚAHPµÄÎÒ¹úÉúÎï²úÒµ¹ú¼Ê¾ºÕùÁ¦ÆÀ¼Û. ¿Æ¼¼¹ÜÀíÑо¿, 2010, 30(10): 32-34.
[13] Global Status of Commercialized Biotech/GM Crops in 2017[EB/OL].[2020-05-27]. https://www.isaaa.org/resources/publications/briefs/53/download/isaaa-brief-53-2017.pdf.
[14] Global bioenergy statistics 2019[EB/OL].[2020-05-27]. https://worldbioenergy.org/uploads/191129%20WBA%20GBS%202019_HQ.pdf.
[15] A sustainable bioeconomy for Europe: Strengthening the connection between economy, society and the environment[EB/OL].[2020-05-27]. https://ec.europa.eu/research/bioeconomy/pdf/ec_bioeconomy_strategy_2018.pdf.
[16] Hern¨¢ndez H, Grassano N, T¨¹bke A, et al. The 2017 EU industrial R & D investment scoreboard. Luxembourg: Publications Office of the European Union, 2017, 66.
[17] Hern¨¢ndez H, Grassano N, T¨¹bke A, et al. The 2019 EU industrial R & D investment scoreboard. Luxembourg: Publications Office of the European Union, 2019, 62.
[18] Morrison C. Boom: 2018's biotech IPOs. Nat Rev Drug Discov, 2019, 18(1): 3-6.
[19] Sun L, Lei LH. Development of venture capital market urgently needed in the construction of sci-tech innovation board ¡ª Empirical analysis based on American data. Sci Technol Economy, 2020, 33(1): 61-65 (in Chinese).
ËïÁú, À×Á¼º£. ¿Æ´´°å½¨ÉèؽÐè´´Òµ·çÏÕͶ×ÊÊг¡µÄ·¢Õ¹¡ª¡ª»ùÓÚÃÀ¹úÄÉ˹´ï¿ËºÍ´´Òµ·çÏÕͶ×ʵÄʵ֤·ÖÎö. ¿Æ¼¼Óë¾­¼Ã, 2020, 33(1): 61-65.
[20] Global and growing: UK biotech financing in 2019[EB/OL].[2020-05-27]. https://www.bioindustry.org/uploads/assets/uploaded/cc26cb0f-3097-43f4-9b5a6d0008941b2d.pdf.
[21] Jiang YH, Zhao WH. The role of research-oriented universities in regional innovation cluster: cases of five biopharmaceutical clusters in the United States. Res Higher Edu Eng, 2017, 35(5): 102-108 (in Chinese).
½­Óýºã, ÕÔÎÄ»ª. Ñо¿ÐÍ´óѧÔÚÇøÓò´´Ð¼¯ÈºÖеÄ×÷ÓÃÑо¿:ÒÔÃÀ¹úÎå´óÉúÎïÒ½Ò©¼¯¾ÛÇøΪÀý. ¸ßµÈ¹¤³Ì½ÌÓýÑо¿, 2017, 35(5): 102-108.
[22] Zhang P, Zhang Y. Design of development roadmap and policy roadmap for biotech industry in China. J Huazhong Agric Univ: Soc Sci Ed, 2013, 15(1): 1-5 (in Chinese).
ÕÅƽ, ÕÅêÊ. ÎÒ¹úÉúÎï¼¼Êõ²úÒµ·¢Õ¹Óë²úÒµÕþ²ß·Ïßͼ¹¹Ïë. »ªÖÐÅ©Òµ´óѧѧ±¨:Éç»á¿Æѧ°æ, 2013, 15(1): 1-5.

Ïà¹Ø»°Ìâ/ÉúÎï ÉúÎï¼¼Êõ ÄÜÔ´ ¹«Ë¾ ×÷Îï

  • ÁìÏÞʱ´ó¶îÓÅ»Ýȯ,Ïí±¾Õ¾Õý°æ¿¼Ñп¼ÊÔ×ÊÁÏ!
    ´ó¶îÓÅ»Ýȯ
    ÓÅ»ÝȯÁìÈ¡ºó72СʱÄÚÓÐЧ£¬10ÍòÖÖ×îп¼Ñп¼ÊÔ¿¼Ö¤Ààµç×Ó´òÓ¡×ÊÁÏÈÎÄãÑ¡¡£º­¸ÇÈ«¹ú500ÓàËùԺУ¿¼ÑÐרҵ¿Î¡¢200¶àÖÖÖ°Òµ×ʸñ¿¼ÊÔ¡¢1100¶àÖÖ¾­µä½Ì²Ä£¬²úÆ·ÀàÐÍ°üº¬µç×ÓÊé¡¢Ìâ¿â¡¢È«Ì××ÊÁÏÒÔ¼°ÊÓƵ£¬ÎÞÂÛÄúÊÇ¿¼Ñи´Ï°¡¢¿¼Ö¤Ë¢Ì⣬»¹ÊÇ¿¼Ç°³å´ÌµÈ£¬²»Í¬ÀàÐ͵IJúÆ·¿ÉÂú×ãÄúѧϰÉϵIJ»Í¬ÐèÇó¡£ ...
    ±¾Õ¾Ð¡±à FreeÒ¼°Û·ÖѧϰÍø 2022-09-19
  • ϸ°ûÄÚÉúÎï´ó·Ö×ÓµÄÏà·ÖÀëÑо¿½øÕ¹
    Àî»Ý1,ÁõÇìϲ1,Àîоü1,½ÃÇ¿1,ÂíÎĽ¨1,21.Æë³Àí¹¤Ñ§Ôº£¬É½¶«¼ÃÄÏ250200;2.Ìì½ò¿Æ¼¼´óѧ£¬Ìì½ò300457ÊÕ¸åÈÕÆÚ£º2019-10-15£»½ÓÊÕÈÕÆÚ£º2020-04-08£»ÍøÂç³ö°æʱ¼ä£º2020-05-15»ù½ðÏîÄ¿£º¹ú¼ÒÖصãÑз¢¼Æ»®(No.2018YFA0901700)×ÊÖúÕªÒª£ºÏ¸°ûÄÚ ...
    ±¾Õ¾Ð¡±à Free¿¼Ñп¼ÊÔ 2021-12-26
  • ¿¹¾úëĵĿ¹ÉúÎïĤ»úÀíÑо¿½øÕ¹
    ÍôÎIJ©,Íõ¹ÚÄÐ,²Ìɯɯ¼ÃÄþҽѧԺҽҩ¹¤³ÌѧԺҽҩ×éÖ¯¹¤³ÌʵÑéÊÒ£¬É½¶«¼ÃÄþ272000ÊÕ¸åÈÕÆÚ£º2019-11-13£»½ÓÊÕÈÕÆÚ£º2020-01-20»ù½ðÏîÄ¿£º¹ú¼Ò×ÔÈ»¿Æѧ»ù½ð(No.31900328)£¬¼ÃÄþҽѧԺ´óѧÉú´´ÐÂѵÁ·¼Æ»®ÏîÄ¿(No.S201910443031)×ÊÖúÕªÒª£ºÉúÎïĤ£¬Ò²³ÆΪÉúÎﱻĤ ...
    ±¾Õ¾Ð¡±à Free¿¼Ñп¼ÊÔ 2021-12-26
  • Ó¼³æ²Ý¾úÉúÎïºÏ³É³æ²ÝËصÄÑо¿½øÕ¹
    ÕÔÐÇÔÂ1,ÀîÙ»2,ÁõÎľ²1,¹Øº£Çç1,Àî³É1,Íõ¼Ê»Ô1,3,ÍõÁÁ11.´óÁ¬¹¤Òµ´óѧÉúÎ﹤³ÌѧԺ£¬ÁÉÄþ´óÁ¬116034;2.´óÁ¬´óѧÉúÃü¿ÆѧÓë¼¼ÊõѧԺ£¬ÁÉÄþ´óÁ¬116622;3.¶«Ý¸Àí¹¤Ñ§Ôº»¯Ñ§¹¤³ÌÓëÄÜÔ´¼¼ÊõѧԺ£¬¹ã¶«¶«Ý¸523808ÊÕ¸åÈÕÆÚ£º2019-11-29£»½ÓÊÕÈÕÆÚ£º2020-03-03»ù½ðÏî ...
    ±¾Õ¾Ð¡±à Free¿¼Ñп¼ÊÔ 2021-12-26
  • ľÊíHSP21»ùÒòµÄµç×Ó¿Ë¡ÓëÉúÎïÐÅϢѧ·ÖÎö
    ¶ÅÉйã,ÓನÄϲýʦ·¶Ñ§ÔºÉúÎïϵ£¬½­Î÷Äϲý330000ÊÕ¸åÈÕÆÚ£º2019-11-12£»½ÓÊÕÈÕÆÚ£º2020-01-09»ù½ðÏîÄ¿£º½­Î÷Ê¡½ÌÓýÌü¿Æѧ¼¼ÊõÑо¿ÖصãÏîÄ¿(No.GJJ181070),½­Î÷Ê¡¿Æ¼¼¼Æ»®ÏîÄ¿ÖصãÑз¢¼Æ»®(No.20192BBFL60008),Äϲýʦ·¶Ñ§Ôº¿Æ¼¼´´ÐÂÍŶÓÏîÄ¿(No.NSTD ...
    ±¾Õ¾Ð¡±à Free¿¼Ñп¼ÊÔ 2021-12-26
  • L929ϸ°ûÌõ¼þÅàÑø»ùÓÕµ¼ÅàÑøµÄСÊóÔ­´ú¾ÞÊÉϸ°ûÉúÎïѧÌØÐÔ¶Ô±È
    Íõΰ1,ÇØêÝ1,ÍõÑÇÈã1,×Þ½Ú½Ú1,³Â¾²1,³Â½ðÎä1,ÕÅÑã1,¹¢Ã÷1,ÐìÖÒ¶«1,´÷Ãô2,ÅËÀñÁú31.ºÏ·Êʦ·¶Ñ§ÔºÉúÃü¿ÆѧѧԺ£¬°²»ÕºÏ·Ê230601;2.°²»ÕÖÐÒ½Ò©´óѧҩѧԺ£¬°²»ÕºÏ·Ê230012;3.½­ÄÏ´óѧҽѧԺ£¬½­ËÕÎÞÎý214122ÊÕ¸åÈÕÆÚ£º2019-11-19£»½ÓÊÕÈÕÆÚ£º2020-03-03£» ...
    ±¾Õ¾Ð¡±à Free¿¼Ñп¼ÊÔ 2021-12-26
  • ¼×ËáÉúÎïÀûÓõÄÑо¿½øÕ¹
    ÐìÈØ1,2*,µËÍõæ­Ó±1,2*,½ªÎÀºì1,¹ËÑô11.Öйú¿ÆѧԺ·Ö×ÓÖ²Îï¿Æѧ׿Խ´´ÐÂÖÐÐÄÖ²ÎïÉúÀíÉú̬Ñо¿ËùºÏ³ÉÉúÎïѧÖصãʵÑéÊÒ£¬ÉϺ£200032;2.Öйú¿ÆѧԺ´óѧ£¬±±¾©100039ÊÕ¸åÈÕÆÚ£º2020-01-09£»½ÓÊÕÈÕÆÚ£º2020-03-20£»ÍøÂç³ö°æʱ¼ä£º2020-04-08»ù½ðÏîÄ¿£º¹ú¼ÒÖصãÑз¢ ...
    ±¾Õ¾Ð¡±à Free¿¼Ñп¼ÊÔ 2021-12-26
  • ÒìÑøͬ»¯½µ½âÂÈ´úÌþµÄÑо¿ÏÖ×´¡¢Î¢ÉúÎï´úлÌØÐÔ¼°Õ¹Íû
    ÕźÆ1,ÐÏÖ¾ÁÖ1,Íô¾ü2,ÕÔÌìÌÎ11.ÖØÇìÀí¹¤´óѧ»¯Ñ§»¯¹¤Ñ§Ôº£¬ÖØÇì400050;2.ÖØÇìÊл·¾³¿ÆѧÑо¿Ôº£¬ÖØÇì401147ÊÕ¸åÈÕÆÚ£º2019-10-12£»½ÓÊÕÈÕÆÚ£º2020-04-09£»ÍøÂç³ö°æʱ¼ä£º2020-05-15»ù½ðÏîÄ¿£º¹ú¼Ò×ÔÈ»¿Æѧ»ù½ð(No.51978117),ÖØÇìÊм¼Êõ´´ÐÂÓëÓ¦ÓÃʾ·¶ ...
    ±¾Õ¾Ð¡±à Free¿¼Ñп¼ÊÔ 2021-12-26
  • ÉúÎïºÏ³É3-ôÇ»ù±ûËáµÄ´úл¹¤³ÌÑо¿½øÕ¹
    Õ²ÔªÁú,ÕÔÈðÓ¢,´ÞºèÁÁ,À̩,ËÎÖ¾·å,Áõ³¤Àò¶«±±ÁÖÒµ´óѧÉúÃü¿ÆѧѧԺ£¬ºÚÁú½­¹þ¶û±õ150040ÊÕ¸åÈÕÆÚ£º2019-09-03£»½ÓÊÕÈÕÆÚ£º2019-10-10»ù½ðÏîÄ¿£ºÖÐÑë¸ßУÑо¿ÏîÄ¿(Nos.2572018CJ01,2572019BD05)£¬¹ú¼Ò×ÔÈ»¿Æѧ»ù½ð(No.51678120)×ÊÖúÕªÒª£º3- ...
    ±¾Õ¾Ð¡±à Free¿¼Ñп¼ÊÔ 2021-12-26
  • »ùÓÚÖØ×éÑõ»¯ÆÏÌÑÌÇËá¸Ë¾úÉúÎïºÏ³ÉßÁ¿©à­ßøõ«
    Ò¶ÈóÀÖ1,Àîãã1,¶¡·²1,ÕÔÕñ»Ô1,³ÂêÉ1,Ô¬½¨·æ1,21.Õ㽭ʦ·¶´óѧÐÐ֪ѧԺ£¬Õã½­À¼Ïª321100;2.Õ㽭ʦ·¶´óѧÕã½­Ê¡Ò°Éú¶¯ÎïÉúÎï¼¼ÊõÓë±£»¤ÀûÓÃÖصãʵÑéÊÒ£¬Õã½­½ð»ª321004ÊÕ¸åÈÕÆÚ£º2019-10-28£»½ÓÊÕÈÕÆÚ£º2020-02-15»ù½ðÏîÄ¿£ºÕã½­Ê¡½ÌÓýÌüÒ»°ãÏîÄ¿(No.Y2018407 ...
    ±¾Õ¾Ð¡±à Free¿¼Ñп¼ÊÔ 2021-12-26
  • ΢ÉúÎïÒÅ´«Ñ§ÓëÓýÖֿγ̽Ìѧ¸Ä¸ïÓë̽Ë÷
    ³Ìпí,ÂíÁúÌì½ò¿Æ¼¼´óѧÉúÎ﹤³ÌѧԺ¹¤Òµ·¢½Í΢ÉúÎï½ÌÓý²¿ÖصãʵÑéÊÒÌì½òÊй¤ÒµÎ¢ÉúÎïÖصãʵÑéÊÒ£¬Ìì½ò300457ÊÕ¸åÈÕÆÚ£º2020-01-09£»½ÓÊÕÈÕÆÚ£º2020-03-18£»ÍøÂç³ö°æʱ¼ä£º2020-04-03»ù½ðÏîÄ¿£º¹ú¼Ò×ÔÈ»¿Æѧ»ù½ð(No.21672161)£¬Ìì½òÊпƼ¼¼Æ»®ÏîÄ¿(No.18PTSY ...
    ±¾Õ¾Ð¡±à Free¿¼Ñп¼ÊÔ 2021-12-26